WallStreetZenWallStreetZen

NASDAQ: VIRI
Virios Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their VIRI stock forecasts and price targets.

Forecast return on equity

Is VIRI forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is VIRI forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

VIRI revenue forecast

What is VIRI's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$12.9M
Avg 2 year Forecast
$52.8M
Avg 3 year Forecast
$80.7M

VIRI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VIRI$0.48N/AN/A
GMDA$0.06$4.75+7,950.85%Strong Buy
MBIO$0.94N/AN/A
SEEL$0.64N/AN/A
AEZS$2.08$15.00+621.15%Buy

Virios Therapeutics Stock Forecast FAQ

What is VIRI's revenue growth forecast for 2027-2029?

(NASDAQ: VIRI) Virios Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Virios Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast VIRI's revenue for 2027 to be $249,197,705, with the lowest VIRI revenue forecast at $249,197,705, and the highest VIRI revenue forecast at $249,197,705. On average, 1 Wall Street analysts forecast VIRI's revenue for 2028 to be $1,015,856,177, with the lowest VIRI revenue forecast at $1,015,856,177, and the highest VIRI revenue forecast at $1,015,856,177.

In 2029, VIRI is forecast to generate $1,554,885,833 in revenue, with the lowest revenue forecast at $1,554,885,833 and the highest revenue forecast at $1,554,885,833.

If you're new to stock investing, here's how to buy Virios Therapeutics stock.

What is VIRI's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VIRI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is VIRI's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VIRI) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.